Elizabeth Douville

Elizabeth Douville, PhD, ICD.D, is an accomplished leader in the biotechnology and life sciences sectors. Currently serving as President and CEO of IRICoR and a founding member of AmorChem, Elizabeth has extensive experience in venture capital with a focus on research innovation and biotech development. Elizabeth holds multiple board positions, including membership at the Centre de production de produits biologiques (CPPB) inc. and chair at Genome Canada. Educational credentials include a PhD in Biochemistry from the University of Ottawa, a postdoctoral internship at Imperial Cancer Research Fund, and completion of executive programs at HEC Montréal and the Institute of Corporate Directors.